Evidence map›Paper›PMID 31317771›Full record

ArticleAIDS research and human retroviruses2019

Amino Acid Prevalence of HIV-1

Philip L Tzou, Soo-Yon Rhee, Robert W Shafer

Abstract readComparative Study
In one paragraph

Article in AIDS research and human retroviruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philip L TzouDivision of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California.
Soo-Yon RheeDivision of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California.
Robert W ShaferDivision of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California.

Funding

HIV Drug Resistance DatabaseR24AI136618 · NIAID · STANFORD UNIVERSITY · PI ROBERT William SHAFER · 2018 to 2026
$7.3M
NIAID NIH HHS R24 AI136618
6 · The paper itself

Abstract

The presence of many highly unusual HIV-1 mutations at a minority variant threshold by next-generation sequence (NGS) may indicate that a high proportion of variants at or just above the threshold represent PCR errors. The validity of this hypothesis depends on the concept that highly unusual mutations detected by population-based sequencing are also highly unusual within a person's virus population. Highly unusual mutations were defined as mutations with a prevalence <0.01% in group M HIV-1 direct PCR population-based Sanger sequences in the Stanford HIV Drug Resistance Database. Single genome Sanger sequences [single genome sequences (SGSs)] were analyzed because they are not subject to PCR error. Permutation analyses compared the proportion of highly unusual mutations in SGSs with the empirical frequencies of these mutations in repeated random selections of population-based sequences. We created a database of 11,258

Indexed as

Genes, polHigh-Throughput Nucleotide SequencingMutation, MissenseReverse Transcriptase Polymerase Chain ReactionAmino Acid SequenceAmino Acid SubstitutionAPOBEC DeaminasesBase SequenceCodon, TerminatorDatabases, GeneticDatasets as TopicGenetic VariationHIV-1HIV InfectionsHumanspol Gene Products, Human Immunodeficiency VirusAPOBEC DeaminasesCodon, Terminatorpol Gene Products, Human Immunodeficiency VirusRNA, ViralHIV-1 polmutationnext-generation sequencingPCRsingle genome sequencing

Identifiers

PMID31317771
PMCPMC6806363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.